NCT05795218View on ClinicalTrials.gov

directSTIM™ Deep Brain Stimulation System Post-Market Clinical Follow-up Study on Essential Tremor

TerminatedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

June 21, 2021

Primary Completion Date

August 8, 2024

Study Completion Date

August 8, 2024

Conditions
Essential Tremor
Interventions
DEVICE

Deep Brain Stimulation

implant and DBS therapy with the directSTIM™ DBS system

Trial Locations (5)

20246

Universitätsklinikum Hamburg, Hamburg

30625

Medizinische Hochschule Hannover, Hanover

48149

Universitätsklinikum Münster, Münster

79106

Universitätsklinikum Freiburg, Freiburg im Breisgau

01307

Universitätsklinikum Carl Gustav Carus Dresden, Dresden

Sponsors
All Listed Sponsors
lead

Aleva Neurotherapeutics SA

INDUSTRY

NCT05795218 - directSTIM™ Deep Brain Stimulation System Post-Market Clinical Follow-up Study on Essential Tremor | Biotech Hunter | Biotech Hunter